<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-CH5YI5BJ</identifier><date>2013</date><creator>Dobravc Verbič, Matej</creator><relation>documents/doc/C/URN_NBN_SI_doc-CH5YI5BJ_001.htm</relation><relation>documents/doc/C/URN_NBN_SI_doc-CH5YI5BJ_001.pdf</relation><relation>documents/doc/C/URN_NBN_SI_doc-CH5YI5BJ_001.txt</relation><format format_type="issue">1</format><format format_type="volume">64</format><format format_type="type">article</format><format format_type="extent">str. 18-24</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">26965287</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-CH5YI5BJ</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">antikoagulacijska zdravila</subject><subject language_type_id="slv">antitrombotično zdravljenje</subject><subject language_type_id="slv">atrijska fibrilacija</subject><subject language_type_id="slv">možganska kap</subject><title>Atrial fibrillation and antithrombotic therapy</title><title>Atrijska fibrilacija in antitrombotiki</title></Record>